172 related articles for article (PubMed ID: 25531136)
1. PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules.
Fu Y; Gerasimova M; Batz F; Kuczkowski A; Alam Y; Sanders PW; Ronzaud C; Hummler E; Vallon V
Nephron; 2015; 129(1):68-74. PubMed ID: 25531136
[TBL] [Abstract][Full Text] [Related]
2. Reducing αENaC expression in the kidney connecting tubule induces pseudohypoaldosteronism type 1 symptoms during K+ loading.
Poulsen SB; Praetorius J; Damkier HH; Miller L; Nelson RD; Hummler E; Christensen BM
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F300-10. PubMed ID: 26582762
[TBL] [Abstract][Full Text] [Related]
3. Sodium and potassium balance depends on αENaC expression in connecting tubule.
Christensen BM; Perrier R; Wang Q; Zuber AM; Maillard M; Mordasini D; Malsure S; Ronzaud C; Stehle JC; Rossier BC; Hummler E
J Am Soc Nephrol; 2010 Nov; 21(11):1942-51. PubMed ID: 20947633
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity.
Vallon V; Hummler E; Rieg T; Pochynyuk O; Bugaj V; Schroth J; Dechenes G; Rossier B; Cunard R; Stockand J
J Am Soc Nephrol; 2009 Apr; 20(4):721-9. PubMed ID: 19158355
[TBL] [Abstract][Full Text] [Related]
5. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
Zhang H; Zhang A; Kohan DE; Nelson RD; Gonzalez FJ; Yang T
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9406-11. PubMed ID: 15956187
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011
[TBL] [Abstract][Full Text] [Related]
7. PPARγ-induced stimulation of amiloride-sensitive sodium current in renal collecting duct principal cells is serum and insulin dependent.
Chraïbi A; Renauld S
Cell Physiol Biochem; 2014; 33(3):581-93. PubMed ID: 24603133
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron.
Nesterov V; Dahlmann A; Krueger B; Bertog M; Loffing J; Korbmacher C
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1289-99. PubMed ID: 22933298
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.
Guan Y; Hao C; Cha DR; Rao R; Lu W; Kohan DE; Magnuson MA; Redha R; Zhang Y; Breyer MD
Nat Med; 2005 Aug; 11(8):861-6. PubMed ID: 16007095
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.
Zhou L; Liu G; Jia Z; Yang KT; Sun Y; Kakizoe Y; Liu M; Zhou S; Chen R; Yang B; Yang T
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1491-7. PubMed ID: 24005472
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
Renauld S; Tremblay K; Ait-Benichou S; Simoneau-Roy M; Garneau H; Staub O; Chraïbi A
J Membr Biol; 2010 Aug; 236(3):259-70. PubMed ID: 20740360
[TBL] [Abstract][Full Text] [Related]
12. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
Tiwari S; Blasi ER; Heyen JR; McHarg AD; Ecelbarger CM
Pharmacol Res; 2008 May; 57(5):383-92. PubMed ID: 18468451
[TBL] [Abstract][Full Text] [Related]
13. Effect of Angiotensin II on ENaC in the Distal Convoluted Tubule and in the Cortical Collecting Duct of Mineralocorticoid Receptor Deficient Mice.
Wu P; Gao ZX; Zhang DD; Duan XP; Terker AS; Lin DH; Ellison DH; Wang WH
J Am Heart Assoc; 2020 Apr; 9(7):e014996. PubMed ID: 32208832
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
Song J; Knepper MA; Hu X; Verbalis JG; Ecelbarger CA
J Pharmacol Exp Ther; 2004 Feb; 308(2):426-33. PubMed ID: 14593089
[TBL] [Abstract][Full Text] [Related]
15. Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance.
Rubera I; Loffing J; Palmer LG; Frindt G; Fowler-Jaeger N; Sauter D; Carroll T; McMahon A; Hummler E; Rossier BC
J Clin Invest; 2003 Aug; 112(4):554-65. PubMed ID: 12925696
[TBL] [Abstract][Full Text] [Related]
16. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor.
Ronzaud C; Loffing J; Bleich M; Gretz N; Gröne HJ; Schütz G; Berger S
J Am Soc Nephrol; 2007 Jun; 18(6):1679-87. PubMed ID: 17475815
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
[TBL] [Abstract][Full Text] [Related]
18. Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?
Goltsman I; Khoury EE; Winaver J; Abassi Z
Pharmacol Ther; 2016 Dec; 168():75-97. PubMed ID: 27598860
[TBL] [Abstract][Full Text] [Related]
19. Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting duct.
Li L; Garikepati RM; Tsukerman S; Kohan D; Wade JB; Tiwari S; Ecelbarger CM
Am J Physiol Renal Physiol; 2013 Feb; 304(3):F279-88. PubMed ID: 23195676
[TBL] [Abstract][Full Text] [Related]
20. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
